Trial Profile
ONO-2745 Phase II study multi-center, randomized, parallel-group study in postoperative patients requiring sedation during artificial ventilation in intensive care unit
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 23 May 2016
Price :
$35
*
At a glance
- Drugs Remimazolam (Primary)
- Indications Sedation
- Focus Therapeutic Use
- Sponsors Ono Pharmaceutical
- 04 Apr 2014 New trial record